AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Viral Hepatitis

Institute of Medicine Expert Committee Assessing Feasibility of Viral Hepatitis Elimination Targets in the U.S.

Corinna Dan

In 2014, the World Health Organization’s (WHO) World Health Assembly unanimously adopted resolution WHA67.6, [PDF 152 KB] which urged Member States and the WHO Director-General to enhance efforts in viral hepatitis surveillance, prevention, treatment access, and disease control. This resolution tasked the WHO with assessing the feasibility of elimination targets for hepatitis B (HBV) and…

Drs. Wolitski and Mermin Discuss Highlights of CDC Presentations at CROI 2016 (Videos)

croi2016logo

While at the 2016 Conference on Retroviruses and Opportunistic Infections (CROI)  in Boston last week, Dr. Rich Wolitski, Acting Director of the HHS Office of HIV/AIDS and Infectious Disease Policy, had an opportunity speak with Dr. Jono Mermin, Director of the CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, about highlights of some…

Research Update: NIH’s Dr. Dieffenbach on CROI 2016 (Video)

drcarl

As the 2016 Conference on Retroviruses and Opportunistic Infections (CROI)  came to a close in Boston on February 25, we spoke with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), about some of the highlights of the HIV research presented there. He notes that there…

Scientific Advances in HIV and HCV To Be Examined Next Week at CROI 2016

croi2016logo

The 2016 Conference on Retroviruses and Opportunistic Infections (CROI) takes place next week in Boston, and AIDS.gov will be there. This annual scientific meeting brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related…

HepCure: Free Hepatitis C App Available for Patients and Providers to Connect and Cure

HepCure

The Centers for Disease Control and Prevention estimate that more than half of all people living with hepatitis C in the U.S. are unaware of their infection and only 9% have been successfully treated and cured, despite the availability of well-tolerated curative treatments for the past several years. A major priority of the Action Plan…

In Appreciation of Dr. Ron Valdiserri’s 27 Years of Federal Service

Dr. Mermin & Dr. Valdiserri

At the end of 2015, we bid farewell to Dr. Ron Valdiserri, who retired from an exemplary career in Federal service. Over many years, Ron played key roles in the Federal responses to HIV and viral hepatitis, most recently as Deputy Assistant Secretary for Health, Infectious Diseases, and the Director of the HHS Office of…

Enhancing the Lives of Americans Living With HIV/AIDS, and Fighting the HIV/AIDS Epidemic

whitehouse2016budget

Editor’s Note: President Obama released his Fiscal Year 2017 budget proposal today. The White House also issued this fact sheet to highlight the budget’s investment in domestic HIV/AIDS activities across federal departments and agencies. Meeting Our Greatest Challenges: The President’s Fiscal Year 2017 Budget Under the President’s leadership, we have turned our economy around and…

Califf, FDA top officials call for sweeping review of agency opioids policies

FDA

Editor’s Note: Reducing opioid misuse not only reduces deaths from overdose but is also key to reducing new HIV and viral hepatitis infections among persons who inject drugs. For more on the link between opioid misuse, HIV and viral hepatitis, see this CDC report. In response to the opioid abuse epidemic, today Dr. Robert Califf, the…